Abstract human figure and data visualizing the health impact of Novo Nordisk weight loss drugs after price cuts
Healthcare & Pharmaceuticals, Business

Novo Nordisk Weight Loss Drugs Get Cheaper, But Who Really Wins?

Novo Nordisk weight loss drugs just got significantly cheaper for many Americans, at least on paper. The company has slashed direct to consumer prices for its blockbuster GLP 1 treatments Wegovy and Ozempic to about 349 dollars per month for existing cash paying patients, with […]